SALAZAC

This brand name is authorized in Japan

Active ingredients

The drug SALAZAC contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Salicylamide UNII `EM8BM710ZC` - SALICYLAMIDE
	Read more about Salicylamide
`2`	Paracetamol UNII `362O9ITL9D` - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol
`3`	Caffeine UNII `3G6A5W338E` - CAFFEINE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine
`4`	Promethazine UNII `75S19OE56R` - PROMETHAZINE METHYLENEDISALICYLATE
	Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.
	Read more about Promethazine

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
JP	医薬品医療機器総合機構	1180107D1107

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.